Leaflet: information for the user
ANTIVERRUGAS ISDIN colodion
Salicylic acid / Lactic acid
Read the entire leaflet carefully before starting to use this medicine, as it contains important information for you.
Follow the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.
Contents of the leaflet
It contains salicylic acid and lactic acid as active ingredients and belongs to the group of anti-wart medicines. When applied to the skin, it produces softening and subsequent destruction of the stratum corneum, allowing the elimination of warts.
Antiverrugas Isdin is indicated for the treatment of cutaneous warts.
Do not use Antiverrugas Isdin:
Warnings and precautions
Consult your doctor or pharmacist before starting to use Antiverrugas Isdin.
For external use only. Do not ingest.
Avoid contact with eyes, mucous membranes, and healthy skin. Rinse with water for 15 minutes if the liquid comes into contact with the eyes or other mucous membranes or skin that is not to be treated.
Highly flammable. Avoid smoking during application and keep the bottle away from flames or heat.
Caution is required when using this medicine in the following cases:
Patients with renal and/or hepatic insufficiency, if they use the product for a long time or extensively, may experience side effects.
Elderly people
Elderly people may be more likely to have blood vessel problems, which should be taken into account due to the possibility of side effects.
Children and adolescents
Antiverrugas ISDIN is contraindicated in children under 2 years of age.
In children between 2 and 12 years old, it should only be used under medical control.
Using Antiverrugas Isdin with other medicines
Antiverrugas Isdin should not be used in conjunction with other similar products (keratolytics) in the same area, as the effect of its components may be enhanced.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
There is no information available on the use of this medicine in pregnant women. As a precaution, it is recommended to avoid using Antiverrugas Isdin during pregnancy.
Oral forms (e.g., tablets) of this class of medicine may cause side effects in the fetus. It is unknown whether the same risks apply to Antiverrugas Isdin when used for warts.
You should not use Antiverrugas Isdin during breastfeeding, except if it is clearly necessary, weighing the potential benefits against the potential risks to the child/baby.
Driving and using machines
The use of this medicine does not affect the ability to drive or operate machines.
Follow the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
Cutaneous use (on the skin).
The recommended dose is:
Apply to the wart or warts once a day.
Before applying Antiverrugas Isdin, it is recommended to rub the surface of the wart with a file.
Apply a drop of Antiverrugas Isdin to the wart to be treated with the spatula, avoiding contact with the surrounding healthy skin area, as it may cause redness and/or burns. Protect this area with an oily ointment or cream (vaseline).
Let it dry and cover with a band-aid for 12 hours. Repeat the operation until the complete disappearance of the wart.
Consult your doctor if the warts are numerous or if infection or inflammation occurs.
Although 12 weeks of treatment may be necessary, consult your doctor if no improvement is seen after 2 weeks.
If you use more Antiverrugas Isdin than you should
Due to the route of administration of this medicine (cutaneous use), intoxication is unlikely.
In case of accidental application to the eyes or mucous membranes, rinse with plenty of water.
In the event of accidental ingestion by mouth, systemic toxicity symptoms due to salicylates may occur. Administer liquids, such as water.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or go to a medical center or call the Toxicology Information Service, phone 91 562 04 20, indicating the product and the amount ingested.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Redness, inflammation, and even ulceration or burning may occur in the healthy skin areas surrounding the wart. If any of these symptoms occur, treatment should be suspended until the irritation disappears, and when continuing, care should be taken to ensure that the medicine only comes into contact with the wart(s).
An allergic reaction to the medicine may occur.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: http://www.aemps.es/.
By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
No special storage conditions are required.
As it is highly flammable, keep the bottle tightly closed and away from flames or heat.
Do not use this medicine after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the pharmacy's SIGRE point. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Antiverrugas Isdin colodion
Appearance of the product and package contents
Antiverrugas Isdin is a colodion, a colorless or slightly yellowish viscous liquid with an ether smell.
It is presented in a 20 ml glass bottle with colodion.
Marketing authorization holder and manufacturer
Holder
ISDIN, S.A.
Provençals, 33
08019 Barcelona
Manufacturer
Meribel Pharma Parets, S.L.U.
Ramon y Cajal, 2
08150 Parets del Vallés
Barcelona
Spain
Date of the last revision of this leaflet: November 2024.
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.es/.